• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的流行病学和分子特征:摩洛哥卡萨布兰卡的一项回顾性研究。

Epidemiological and molecular profile of breast cancer: a retrospective study in Casablanca, Morocco.

作者信息

Khadiri Khadija, Khadrouf Zineb, Mellouki Abderrahmane, Bouchra Oumaima, Essalihi Amina, Naya Abdallah, Benchekroun Majda Taoudi, Karkouri Mehdi

机构信息

Laboratory of Immunology and Biodiversity, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.

Department of Pathology, University Hospital Center Ibn Rochd, Casablanca, Morocco.

出版信息

Pan Afr Med J. 2025 Apr 22;50:105. doi: 10.11604/pamj.2025.50.105.43868. eCollection 2025.

DOI:10.11604/pamj.2025.50.105.43868
PMID:40656144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12245639/
Abstract

INTRODUCTION

breast cancer is a major public health concern in Morocco due to delayed diagnosis and treatment, largely due to its high incidence. It is the most prevalent cancer in women. This study aimed to report the epidemiological and the molecular profile of invasive breast carcinoma using surrogate immunohistochemical markers.

METHODS

during 24 months from 1 January 2020 to 31 December 2021 at the Pathology Department of Ibn Rochd University Hospital of Casablanca, Morocco, we conducted a retrospective study comprised 1,558 breast cancer cases, including male patients. The generated data was analyzed using GraphPad Prism 8 software to define the epidemiological and molecular features of breast cancer.

RESULTS

this epidemiological study reveals that the mean age of patients was 52 ± 12.27 years. The most common histological type is invasive breast carcinoma of no special type, which accounts for 90.5% (n=1,410) of cases. Regarding Ellis and Elston modified Scarff-Bloom-Richardson (SBR) grade, grade III was the most common, 52.2% (n=521), followed by grade II, 44% (n=438), and grade I, 3.8% (n=38), as assessed by the SBR grade. The molecular classification results indicate that luminal B was the most common subtype at 52.2% (n=441), followed by triple-negative at 19.6% (n=166), with HER2 phenotype representing 17.4% (n=147) and luminal A at 10.8% (n=91).

CONCLUSION

this study highlights that invasive breast carcinoma of no special type is the most common type, with grade III tumors being the most frequent. The majority of cases were luminal B, underscoring the need for targeted therapeutic strategies.

摘要

引言

由于诊断和治疗延迟,乳腺癌在摩洛哥是一个主要的公共卫生问题,这在很大程度上归因于其高发病率。它是女性中最常见的癌症。本研究旨在使用替代免疫组化标志物报告浸润性乳腺癌的流行病学和分子特征。

方法

在2020年1月1日至2021年12月31日的24个月期间,在摩洛哥卡萨布兰卡伊本·罗什德大学医院病理科,我们进行了一项回顾性研究,纳入了1558例乳腺癌病例,包括男性患者。使用GraphPad Prism 8软件对生成的数据进行分析,以确定乳腺癌的流行病学和分子特征。

结果

这项流行病学研究显示,患者的平均年龄为52±12.27岁。最常见的组织学类型是无特殊类型的浸润性乳腺癌,占病例的90.5%(n = 1410)。根据埃利斯和埃尔斯顿改良的斯卡夫-布鲁姆-理查森(SBR)分级,III级最为常见,占52.2%(n = 521),其次是II级,占44%(n = 438),I级占3.8%(n = 38)。分子分类结果表明,腔面B型是最常见的亚型,占52.2%(n = 441),其次是三阴性,占19.6%(n = 166),HER2表型占17.4%(n = 147),腔面A型占10.8%(n = 91)。

结论

本研究强调无特殊类型的浸润性乳腺癌是最常见的类型,III级肿瘤最为常见。大多数病例为腔面B型, 这突出了针对性治疗策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/12245639/118f24c45b7b/PAMJ-50-105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/12245639/118f24c45b7b/PAMJ-50-105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/12245639/118f24c45b7b/PAMJ-50-105-g001.jpg

相似文献

1
Epidemiological and molecular profile of breast cancer: a retrospective study in Casablanca, Morocco.乳腺癌的流行病学和分子特征:摩洛哥卡萨布兰卡的一项回顾性研究。
Pan Afr Med J. 2025 Apr 22;50:105. doi: 10.11604/pamj.2025.50.105.43868. eCollection 2025.
2
The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status.早期乳腺癌患者 HER2-低表达的临床病理特征及预后意义:激素受体状态分层的 HER2-低表达与 HER2 阴性乳腺癌的预后比较。
Breast J. 2023 Nov 30;2023:6621409. doi: 10.1155/2023/6621409. eCollection 2023.
3
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
4
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Epidemiological profile of breast cancer in a reference center in the north region of Brazil.巴西北部某参考中心的乳腺癌流行病学概况
Rev Bras Ginecol Obstet. 2025 May 4;47. doi: 10.61622/rbgo/2025rbgo27. eCollection 2025.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Immunohistochemical-Based Molecular Subtypes of Female Breast Cancer: A Retrospective Cross-Sectional Study at Cheikh Khalifa Hospital in Casablanca, Morocco.免疫组织化学基于女性乳腺癌的分子亚型:摩洛哥卡萨布兰卡谢赫·哈利法医院的回顾性横断面研究。
Cancer Control. 2024 Jan-Dec;31:10732748241300655. doi: 10.1177/10732748241300655.
2
Determining breast cancer biomarker status and associated morphological features using deep learning.使用深度学习确定乳腺癌生物标志物状态及相关形态学特征。
Commun Med (Lond). 2021 Jul 14;1:14. doi: 10.1038/s43856-021-00013-3. eCollection 2021.
3
Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer.
Ki-67作为浸润性乳腺癌的预后生物标志物
Cancers (Basel). 2021 Sep 3;13(17):4455. doi: 10.3390/cancers13174455.
4
Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches.乳腺癌治疗与生物标志物:过去、现在及未来的方法
Breast Cancer (Auckl). 2021 Mar 24;15:1178223421995854. doi: 10.1177/1178223421995854. eCollection 2021.
5
[Epidemiological and anatomopathological profile of breast cancer at the Ibn Rochd University Hospital, Casablanca].[卡萨布兰卡伊本·罗什德大学医院乳腺癌的流行病学和解剖病理学特征]
Pan Afr Med J. 2020 Sep 9;37:41. doi: 10.11604/pamj.2020.37.41.21336. eCollection 2020.
6
Molecular Classification of Breast Cancer.乳腺癌的分子分类。
Adv Anat Pathol. 2020 Jan;27(1):27-35. doi: 10.1097/PAP.0000000000000232.
7
Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies?全球乳腺癌的发病率和死亡率模式与各国特定的经济发展及预防策略有关吗?
J Glob Oncol. 2018 Jul;4:1-16. doi: 10.1200/JGO.17.00207.
8
Risk Factors and Preventions of Breast Cancer.乳腺癌的风险因素与预防。
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. eCollection 2017.
9
[Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center].[乳腺癌HER2状态检测的内部质量控制:某癌症中心的经验]
Bull Cancer. 2017 Jul-Aug;104(7-8):608-617. doi: 10.1016/j.bulcan.2017.05.002. Epub 2017 Jun 7.
10
High prevalence of luminal B breast cancer intrinsic subtype in Colombian women.哥伦比亚女性中腔面B型乳腺癌内在亚型的高患病率。
Carcinogenesis. 2016 Jul;37(7):669-676. doi: 10.1093/carcin/bgw043. Epub 2016 Apr 16.